5-[7-(2,3-difluorophenyl)imidazo[1,5-b]pyridazin-4-yl]-2-methyl-N-(4-methylphenyl)pyridine-3-carboxamide
C26H19F2N5O — CID 160683858
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[7-(2,3-difluorophenyl)imidazo[1,5-b]pyridazin-4-yl]-2-methyl-N-(4-methylphenyl)pyridine-3-carboxamide
5-[7-(2,3-difluorophenyl)imidazo[1,5-b]pyridazin-4-yl]-2-methyl-N-(4-methylphenyl)pyridine-3-carboxamide (PubChem CID 160683858) has the molecular formula C26H19F2N5O and a molecular weight of 455.47 g/mol. Its IUPAC name is 5-[7-(2,3-difluorophenyl)imidazo[1,5-b]pyridazin-4-yl]-2-methyl-N-(4-methylphenyl)pyridine-3-carboxamide.
Molecular Properties
| Compound Name | 5-[7-(2,3-difluorophenyl)imidazo[1,5-b]pyridazin-4-yl]-2-methyl-N-(4-methylphenyl)pyridine-3-carboxamide |
|---|---|
| PubChem CID | 160683858 |
| Molecular Formula | C26H19F2N5O |
| Molecular Weight | 455.47 g/mol |
| Exact Mass | 455.16 |
| IUPAC Name | 5-[7-(2,3-difluorophenyl)imidazo[1,5-b]pyridazin-4-yl]-2-methyl-N-(4-methylphenyl)pyridine-3-carboxamide |
| SMILES | Cc1ccc(NC(=O)c2cc(-c3ccnn4c(-c5cccc(F)c5F)ncc34)cnc2C)cc1 |
| InChI | InChI=1S/C26H19F2N5O/c1-15-6-8-18(9-7-15)32-26(34)21-12-17(13-29-16(21)2)19-10-11-31-33-23(19)14-30-25(33)20-4-3-5-22(27)24(20)28/h3-14H,1-2H3,(H,32,34) |
| InChIKey | ROMPNNFADVDXGJ-UHFFFAOYSA-N |
| XLogP | 5.61 |
| TPSA | 72.18 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 455.47 |
| LogP ≤ 5 | 5.61 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 160683858 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.